Papers
1
Total Citations
4
H-Index
1
About
Dr. Xi-Qiu Liu is a pioneering researcher in cancer therapeutics, with a primary focus on developing advanced in vitro models for evaluating chemo-immunotherapy strategies. Her most notable contribution is the creation of a facile automated multiple-well platform that cultures immunized tumor organoids within ECM-mimicked hydrogels, a breakthrough designed to address the critical challenge of drug resistance in breast cancer. This innovative system allows for the high-throughput, physiologically relevant assessment of combined chemotherapy and immunotherapy regimens, offering a powerful tool to predict patient-specific treatment responses before clinical application. Her 2025 paper on this platform has already garnered 4 citations, signaling its immediate impact and potential to transform preclinical drug evaluation. By bridging the gap between traditional 2D cultures and complex in vivo models, Dr. Liu’s work directly tackles the ineffectiveness of single-agent immunotherapies and the development of chemoresistance, paving the way for more effective, personalized cancer treatments. Her research stands at the forefront of organoid technology and biomimetic materials, offering a tangible path toward improved clinical outcomes for breast cancer patients.
Research Focus
Key Achievements
Top Papers
- 1